| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
IOVA
Iovance Biotherapeutics
|
Aug 25, 2026 | BUY |
Strong Buy
+65.6% avg upside
25 analysts
|
$10.00
24.94% Upside
|
-5.1% | · |
|
KROS
Keros Therapeutics
|
Aug 21, 2026 | HOLD |
Strong Buy
+117.6% avg upside
21 analysts
|
— | +0.8% | · |
|
IMTX
Immatics
|
Aug 18, 2026 | BUY |
Strong Buy
+92.4% avg upside
15 analysts
|
— | +3.0% | · |
|
ARVN
Arvinas Holding Company
|
Aug 04, 2026 | HOLD |
Buy
+212.2% avg upside
28 analysts
|
— | +2.0% | · |
|
KNSA
Kiniksa Pharmaceuticals
|
Jul 28, 2026 | BUY |
Strong Buy
-0.9% avg upside
11 analysts
|
$95.00
21.74% Upside
|
-1.7% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.